BRCA1 and ovarian carcinoma: A case–control study by Kotsopoulos et al. from 2006 found no increase in ovarian cancer risk associated with use of HRT in BRCA1/2 mutation carriers (OR = 0.93; 95% CI 0.56–1.56; P = 0.79) (Kotsopoulos et al. 2006).